Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.68    0.03 (0.65%)
Bid:
4.61
Ask:
4.695
Spread: 0.085 (1.844%)
Market Cap: £224.62m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Director Dealing

30 Apr 2014 12:27

RNS Number : 9183F
Seeing Machines Limited
30 April 2014
Β 

ο»Ώ

Seeing Machines Limited

("Seeing Machines" or the "Company")

Β 

Director Dealing

Β 

Seeing Machines Limited (AIM: SEE), the AIM-listed technology company with a focus on computer vision based operator monitoring and intervention technology and services, announces that it was informed on 30 April 2014 that Mike Roberts, a non-executive director of the Company, sold 2,190,000 ordinary shares in the Company ("Ordinary Shares") at a price of 6.25 pence per share on 29 April 2014. Mike sold the shares to Ken Davis, Seeing Machines' recently appointed Senior Vice President - Sales & Marketing, to enable him to procure this stake in the Company.

Β 

Following the transaction, Mr. Roberts retains a beneficial interest in 13,495,376 Ordinary Shares, representing 1.64% of the Company's issued share capital.

Β 

Enquiries:

Β 

Seeing Machines Limited

www.seeingmachines.com

Ken Kroeger, Managing Director and CEO

+61 2 6103 4700

Ken.Kroeger@seeingmachines.com

James Walker, CFO

+61 2 6103 4700

James.Walker@seeingmachines.com

Β 

finnCap Ltd

Ed Frisby / Ben Thompson, Corporate Finance

+44 20 7220 0500

Simon Starr/Victoria Bates, Corporate Broking

Β 

Newgate Threadneedle, Investment Communications for Seeing Machines

Graham Herring

Tel:Β +44 20 7653 9858

Mob:Β +44 7793 839 024

g.herring@newgatethreadneedle.com

Β 

Robyn McConnachie

Tel:Β +44 20 7653 9852

Mob:Β +44 7540 706 191

r.mcconnachie@newgatethreadneedle.com

Β 

About Seeing Machines

Seeing Machines, (AIM: SEE), is an AIM-listed technology company that specialises in operator monitoring and intervention technologies and services. Its software and engineering services are used in products and applications that range from devices that improve driver safety and save lives to assessing trainees in simulators and simplifying the relationships between people and technology. Seeing Machines technology is used worldwide across the automotive, mining, transport and aviation industries; as well as many of the leading academic research groups and transportation authorities. Seeing Machines is headquartered in Australia and has offices in Tucson, Arizona and San Francisco, California. The company counts Caterpillar, BHP Billiton, Freeport McMoran, MIT, Boeing and General Motors amongst its customers.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSFBLFXZZFLBBQ
Date   Source Headline
11th Mar 20097:00 amRNSReviewed Interim Results
18th Feb 20097:00 amRNSRestructuring of the business
28th Jan 20099:41 amRNSTrading update and notice of results
1st Dec 20088:14 amRNSChange of Registered Office
27th Nov 20088:08 amRNSResult of AGM
29th Oct 200810:52 amRNSNotice of AGM
23rd Sep 20087:00 amRNSFinal Results
17th Sep 20088:37 amRNSNotice of Final Results
26th Aug 20088:33 amRNSNEW FACEAPI PRODUCT RELEASE
23rd Jul 20087:37 amRNSFirst Expected Profit Report
7th May 20088:08 amRNSNORTH AMERICAN OPERATION
7th Apr 200812:00 pmRNSChange of Broker
4th Mar 20087:59 amRNSInterim Results
4th Mar 20087:51 amRNSMajor contract gain
13th Feb 20088:27 amRNSHolding in Company
28th Dec 20079:11 amRNSAnnual Report
11th Dec 200710:54 amRNSChange of Adviser
29th Nov 200710:03 amRNSAGM Results
8th Nov 200712:38 pmRNSDirector/PDMR Shareholding
8th Nov 200712:34 pmRNSGlaucoma Device at AAO
31st Oct 20079:26 amRNSCompletion of Placing-Replace
31st Oct 20077:01 amRNSCompletion of Placing
26th Oct 20079:35 amRNSShareholder Approval
17th Oct 20072:21 pmRNSDirector/PDMR Shareholding
15th Oct 20079:23 amRNSCFO Appointment
25th Sep 200710:23 amRNSFurther Placing
24th Sep 20071:12 pmRNSFinal Results
24th Sep 20071:00 pmRNSFundraising
15th Aug 200712:43 pmRNSAIM Rule 26 Compliance
15th Aug 20079:27 amRNSFDA Approval for Truefield
2nd Jul 20077:01 amRNSNew Product Releases
29th Jun 200710:11 amRNSMaster License Agreement
22nd May 200711:15 amRNSLicensing agreement signed
8th May 20077:02 amRNSGlaucoma Device Demonstrated
28th Mar 20072:40 pmRNSInterim Results
14th Mar 200710:45 amRNSAward win for glaucoma device
12th Mar 20077:02 amRNSAddition to product released
19th Dec 200610:06 amRNSTotal Voting Rights
30th Nov 20068:27 amRNSAGM Statement
9th Nov 20067:01 amRNSGlaucoma Study Re-commences
2nd Nov 20067:01 amRNSNew Product
19th Oct 20065:38 pmRNSFinal Results - Replacement
19th Oct 200611:29 amRNSFinal Results
18th Oct 200611:04 amRNSDirectorate Change
17th Oct 20063:20 pmRNSNew Version of faceLAB
21st Sep 20064:41 pmRNSIssue of Equity
18th Sep 200611:24 amRNSAutomotive progress
18th Sep 20069:45 amRNSGlaucoma Grant Signed
30th Aug 200611:46 amRNSClinical Study Results
14th Aug 200610:57 amRNSGrant Approval

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.